ZA733763B - N-substituted prostaglandin carboxamides - Google Patents

N-substituted prostaglandin carboxamides

Info

Publication number
ZA733763B
ZA733763B ZA733763A ZA733763A ZA733763B ZA 733763 B ZA733763 B ZA 733763B ZA 733763 A ZA733763 A ZA 733763A ZA 733763 A ZA733763 A ZA 733763A ZA 733763 B ZA733763 B ZA 733763B
Authority
ZA
South Africa
Prior art keywords
substituted prostaglandin
carboxamides
prostaglandin carboxamides
substituted
prostaglandin
Prior art date
Application number
ZA733763A
Inventor
T Schaaf
H Hess
L Czuba
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA733763B publication Critical patent/ZA733763B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
ZA733763A 1972-06-07 1973-06-04 N-substituted prostaglandin carboxamides ZA733763B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26051872A 1972-06-07 1972-06-07

Publications (1)

Publication Number Publication Date
ZA733763B true ZA733763B (en) 1974-04-24

Family

ID=22989486

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA733763A ZA733763B (en) 1972-06-07 1973-06-04 N-substituted prostaglandin carboxamides

Country Status (24)

Country Link
JP (2) JPS5715591B2 (en)
AR (1) AR207434A1 (en)
AT (1) AT340069B (en)
BE (1) BE800580A (en)
CA (1) CA985280A (en)
CH (3) CH591511A5 (en)
CS (1) CS200166B2 (en)
DD (2) DD115687A5 (en)
DE (1) DE2329092A1 (en)
ES (3) ES415611A1 (en)
FI (1) FI58327C (en)
FR (2) FR2187344B1 (en)
GB (2) GB1439511A (en)
HU (3) HU170200B (en)
IE (1) IE38058B1 (en)
IL (2) IL42385A (en)
IN (1) IN138966B (en)
LU (1) LU67754A1 (en)
NL (2) NL160814C (en)
NO (2) NO146538C (en)
PH (2) PH14204A (en)
SE (3) SE415883B (en)
YU (1) YU36498B (en)
ZA (1) ZA733763B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (en) * 1975-04-23 1980-08-22 Upjohn Co PROCEDURE FOR PREPARING ANALOGS OF PROSTAGLANDINAS
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187043A (en) * 1962-05-18 1965-06-01 Monsanto Co Monohalophosphonium halides

Also Published As

Publication number Publication date
IL42385A0 (en) 1973-07-30
CS200166B2 (en) 1980-08-29
NO146538C (en) 1982-10-20
CH593929A5 (en) 1977-12-30
FR2273814B1 (en) 1977-07-08
HU170487B (en) 1977-06-28
LU67754A1 (en) 1973-12-14
NO142784C (en) 1980-10-15
NO740850L (en) 1973-12-10
FR2187344A1 (en) 1974-01-18
ES430416A1 (en) 1976-10-16
JPS5731692A (en) 1982-02-20
DD109211A5 (en) 1974-10-20
ES430417A1 (en) 1977-03-01
IE38058B1 (en) 1977-12-21
NO142784B (en) 1980-07-07
HU170491B (en) 1977-06-28
FR2273814A1 (en) 1976-01-02
IL51525A0 (en) 1977-04-29
HU170200B (en) 1977-04-28
JPS4954350A (en) 1974-05-27
FI58327C (en) 1981-01-12
ATA504873A (en) 1977-03-15
SE415883B (en) 1980-11-10
BE800580A (en) 1973-12-07
IE38058L (en) 1973-12-07
GB1439511A (en) 1976-06-16
NO146538B (en) 1982-07-12
PH13092A (en) 1979-11-27
AU5643173A (en) 1974-12-05
GB1439512A (en) 1976-06-16
YU152673A (en) 1982-02-25
NL160814C (en) 1979-12-17
FI58327B (en) 1980-09-30
FR2187344B1 (en) 1977-10-28
IL42385A (en) 1979-10-31
PH14204A (en) 1981-04-01
SE418744B (en) 1981-06-22
NL7812163A (en) 1979-04-27
CA985280A (en) 1976-03-09
IN138966B (en) 1976-04-17
SE7608224L (en) 1976-07-19
CH605887A5 (en) 1978-10-13
ES415611A1 (en) 1976-07-16
JPS5715591B2 (en) 1982-03-31
AR207434A1 (en) 1976-10-08
NL7307867A (en) 1973-12-11
SE7608225L (en) 1976-07-19
DD115687A5 (en) 1975-10-12
YU36498B (en) 1984-02-29
DE2329092A1 (en) 1974-01-03
AT340069B (en) 1977-11-25
NL160814B (en) 1979-07-16
CH591511A5 (en) 1977-09-30

Similar Documents

Publication Publication Date Title
GB1401219A (en) Combustion process
ZA73517B (en) Complex of 7-dimethylamino-6-demethyl-6-deoxytetracycline hydrochloride
ZA736059B (en) New quinoxaline-di-n-oxide derivatives
PH12257A (en) New pyrazilodiazepine compounds
PH10925A (en) N-(p-loweralkoxybenzyl scopolamonium halide
GB1408261A (en) N-substituted 1-amino-3-phenoxypropan-2-ols
YU35118B (en) Process for preparing n-(1-ethyl-delta-pyrrolyly-methyl)-2-methoxy-5-sulfamidobenzamide
AU6795374A (en) Inhibitors
PH14204A (en) N-substituted prostaglandin carboxamides
ZM673A1 (en) Chemosterilisation of ixodides
ZA73137B (en) Novel benzylpyrimidines
KE2917A (en) New phenylformamidine derivatives
IL42007A0 (en) New 2-benzoyl-3-amino-pyridines
ZM8573A1 (en) Novel triazino-benzimidazoles
ZA734945B (en) New beta-aminoketone derivatives
KR780000089B1 (en) A method for the preparation of n-(1-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-ethylsulfonyl-benzamide
AU488545B2 (en) N-substituted prostaglandin carboxamides
AU6034273A (en) Prostaglandin compounds
ZA733170B (en) Novel thiocarbamylsulfenamides
AU6043173A (en) Process
ZA735128B (en) New trialkoxybenzoylpeptides
ZA733030B (en) New nitrofurl-amidine derivatives
CA889854A (en) N-alkyl-n-polyhalovinylthio carboxamides
IE38677L (en) Prostaglandin derivatives
YU176973A (en) New process for preparing n-(diethyl-amino-ethyl)-2-methoxy-4-amino-5-chloro-benzamides